Midi Health vs Mounjaro

Compare pricing, features, and medications to find the best GLP-1 provider for your weight loss journey

Midi Health vs Mounjaro: Overview

Choosing between Midi Health and Mounjaro for GLP-1 weight loss medication? Both are highly-rated providers, but they differ in pricing, medication options, and service features.

Midi Health offers both semaglutide and tirzepatide at $164/month with a rating of 8.6/10. Mounjaro offers tirzepatide at $1080/month with a 9.2/10 rating.

The price difference of $916/month is significant - Midi Health is the more budget-friendly option, while Mounjaro positions itself as a premium service.

VERIFIED

Our recommended brand

After reviewing all 148 providers on this platform, we've identified CoreAge Rx as offering the most transparent pricing model. At just $99/month — the same price every month, every dose — there are no surprise charges or hidden fees. Combined with exceptional service quality, personalized support, and access to both semaglutide and tirzepatide, it represents the best value without compromising on care.

At a glance

Price Difference
$916/mo
Rating Difference
0.6
Winner
Mounjaro
Best For
Quality

Midi Health

View full Midi Health review →
Rating
8.6/10
Monthly Price
$164Cheaper
Medications
compounded GLP-1compounded GLP-1/GIPbrand-name GLP-1s

Pros

  • The GLP-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked July 28, 2026)
  • Compounded GLP-1 injectable runs $165.90 for the lowest doses, $270.90 in the mid range and $355.00 at the top; the dual-action GLP-1/GIP injectable runs $210.00 to $434.00, all for a 4-week supply
  • Sublingual options are offered as well, from $164.00 for GLP-1 and $209.00 for dual-action GLP-1/GIP, for people who will not inject
  • Its partner compounding pharmacies are 503B-accredited. 503B outsourcing facilities register with the FDA, are subject to current good manufacturing practice requirements and are FDA-inspected - a materially higher standard than the 503A pharmacies most competitors use
  • There is no membership fee. You pay for care and medication only
  • Visits are insurance-covered for qualifying patients, and HSA/FSA funds can be used for copays and services
  • Midi will also prescribe brand-name GLP-1s sent to a pharmacy of your choice, so you are not locked into compounded product if you would rather have the approved drug
  • The efficacy claim is the best-sourced in this category. Midi reports patients lost an average of 16 lbs after six or more months, and footnotes it to a retrospective analysis of 6,958 patients who completed two or more weight management visits between 1 May 2025 and 30 April 2026, while stating plainly that weight data were self-reported and results are not guaranteed
  • Care is genuinely whole-person for midlife women - perimenopause, menopause, weight, mood and memory, sexual wellness, hair and skin, sleep, and cancer survivorship - with lab orders and lifestyle support included where appropriate
  • Available in all 50 states

Cons

  • The compounded products are still not FDA-approved. 503B accreditation raises the manufacturing standard considerably but does not mean the FDA has reviewed these preparations for safety or efficacy
  • Midi never names the active drug anywhere in its pricing. Everything is labelled 'GLP-1' or 'GLP-1/GIP'. The dose ladders shown - 0.25 through 2.5 mg, and 2.5 through 15 mg - match the standard semaglutide and tirzepatide titrations exactly, but you should confirm with the clinician what you are actually being prescribed
  • Microdosing is offered from $34 a week for eligible patients. Microdosing is not an evidence-based protocol - the trials behind these drugs used full therapeutic doses, and the 16 lb outcome figure covers patients on 'a range of treatments', not microdosing specifically
  • Medicaid and Medi-Cal patients cannot be treated at all, even if they offer to pay cash
  • Medicare does not cover Midi, and beneficiaries cannot submit claims for visits, medications or associated services
  • Prices rise steeply as you titrate up. Injectable GLP-1 more than doubles from $165.90 to $355.00, and the dual-action sublingual runs from $209.00 to $460.00, so the entry price is not what you will pay long term
  • The 16 lb average comes from self-reported weights in a retrospective chart review with no control group - well documented, but not a controlled trial
  • GLP-1 medications are not suitable for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, or during pregnancy. Pancreatitis and gallbladder disease are recognised risks
Choose Midi Health

Mounjaro

View full Mounjaro review →
Rating
9.2/10Better
Monthly Price
$1080
Medications
tirzepatide

Pros

  • FDA-approved for type 2 diabetes
  • Weekly injection
  • Effective for weight loss (~15-20%)
  • Dual GIP/GLP-1 mechanism
  • Often covered by insurance for diabetes

Cons

  • Primarily approved for diabetes, not weight loss
  • Requires prescription
  • May cause nausea and digestive issues
  • Supply shortages reported
Choose Mounjaro

Feature-by-feature comparison

FeatureMidi HealthMounjaro
Monthly Price$164$1080
Rating8.6/109.2/10
Medicationscompounded GLP-1, compounded GLP-1/GIP, brand-name GLP-1stirzepatide
Insurance AcceptedYesYes
Support HoursNot publishedMon-Fri 8AM-8PM ET
Live ChatNoNo
Free ShippingYesNo
Shipping SpeedDiscreet shipping included in every quoted medication priceVaries by pharmacy
Mobile AppNoNo
Dedicated CoachNot includedNot included
Follow-up FrequencyContinued care visits with the same clinician, covered by insurance for qualifying patientsAs prescribed by physician
Money-back GuaranteeNone publishedSavings card available ($25 per month for eligible patients)
Cancellation PolicyNo membership fee and no subscription lock-in; you pay for care and medication onlyPrescription-based, consult doctor

Which should you choose?

Choose Midi Health if you:

  • Want to save $916/month with a more affordable option
  • Want more medication options to choose from
  • Value: the glp-1 pricing page is the most transparent we have seen anywhere in this category: a dose-by-dose table for four different products, with shipping and supplies included in every figure (checked july 28, 2026)

Choose Mounjaro if you:

  • Prefer a higher-rated service (9.2/10 vs 8.6/10)
  • Value: fda-approved for type 2 diabetes

Website previews

Midi Health

Midi Health website

Mounjaro

Mounjaro website

Our recommendation

Mounjaro comes out ahead with a higher rating of 9.2/10.
Get started with Mounjaro

Compare other providers

Compare GLP-1 Brands